Particle.news
Health ❯Healthcare ❯Medications
Pharmaceuticals Access to Medication Talk Shows Ethics in AI Medications Diabetes Medications Diagnosis Pharmaceutical Law Drug Sales FDA
Phase III trial results indicate the drug resolves liver inflammation in most patients with MASH and improves fibrosis, with FDA approval under priority review.
